Table 1.

Clinically actionable events

Disease/rhythm-related	Detected atrial tachycardia/fibrillation in patients requiring pace termination, shock, cardioversion, or medication adjustment
	Detected sustained ventricular tachycardia ≥5 beats requiring pace termination, shock, cardioversion, or medication adjustment
	Asystole >3-s pause
Device function	Elective replacement indicator or end of life present
Lead function	Significant changes in atrial or ventricular lead impedance defined as impedance <200 or >2000 Ω, unstable lead impedance deemed to be clinically actionable, ≥50 % change in lead impedance since last interrogation
	Increase in pacing voltage threshold ≥1 V compared with the previous interrogation